MétaCan
Menu
Back to cohort
Record W2910801868 · doi:10.1093/neuonc/noy178

Molecular and translational advances in meningiomas

2018· review· en· W2910801868 on OpenAlexafffund
Suganth Suppiah, Farshad Nassiri, Wenya Linda Bi, Ian F. Dunn, C. Oliver Hanemann, Craig Horbinski, Rintaro Hashizume, C. David James, Christian Mawrin, Houtan Noushmehr, Arie Perry, Felix Sahm, Andrew E. Sloan, Andreas von Deimling, Patrick Y. Wen, Kenneth Aldape, Gelareh Zadeh, Karolyn Au, Jill Barnhartz-Sloan, Priscilla K. Brastianos, Nicholas Butowski, Carlos Gilberto Carlotti, Michael D. Cusimano, Francesco DiMeco, Katharine J. Drummond, Evanthia Galanis, Caterina Giannini, Roland Goldbrunner, Brent Griffith, Christel Herold‐Mende, Raymond Y. Huang, David James, Michael D. Jenkinson, Timothy J Kaufman, Boris Krischek, Daniel H. Lachance, Christian la Fougère, Ian Lee, Jeff C. Liu, Yasin Mamatjan, Alireza Mansouri, Michael McDermott, David G. Muñoz, Ho‐Keung Ng, Farhad Pirouzmand, Laila Poisson, Bianca Pollo, David R. Raleigh, Andrea Saladino, Thomas Santarius, Christian Schichor, David Schultz, Nils Ole Schmidt, Warren R. Selman, Julian Spears, James Snyder, Ghazaleh Tabatabai, Marcos Tatagiba, Daniela Pretti da Cunha Tirapelli, J. C. Tonn, Derek S. Tsang, Michael A. Vogelbaum, Tobias Walbert, Manfred Westphal, Adriana M Workewych

Bibliographic record

VenueNeuro-Oncology · 2018
Typereview
Languageen
FieldMedicine
TopicMeningioma and schwannoma management
Canadian institutionsPrincess Margaret Cancer CentreUniversity of TorontoUniversity Health Network
FundersCanadian Institutes of Health ResearchNational Center for Advancing Translational SciencesNational Institute of Neurological Disorders and StrokeBrain Tumour Charity
KeywordsMeningiomaEpigenomicsMedicineClinical trialDiseaseBioinformaticsPathologyBiology

Abstract

fetched live from OpenAlex

Meningiomas are the most common primary intracranial neoplasm. The current World Health Organization (WHO) classification categorizes meningiomas based on histopathological features, but emerging molecular data demonstrate the importance of genomic and epigenomic factors in the clinical behavior of these tumors. Treatment options for symptomatic meningiomas are limited to surgical resection where possible and adjuvant radiation therapy for tumors with concerning histopathological features or recurrent disease. At present, alternative adjuvant treatment options are not available in part due to limited historical biological analysis and clinical trial investigation on meningiomas. With advances in molecular and genomic techniques in the last decade, we have witnessed a surge of interest in understanding the genomic and epigenomic landscape of meningiomas. The field is now at the stage to adopt this molecular knowledge to refine meningioma classification and introduce molecular algorithms that can guide prediction and therapeutics for this tumor type. Animal models that recapitulate meningiomas faithfully are in critical need to test new therapeutics to facilitate rapid-cycle translation to clinical trials. Here we review the most up-to-date knowledge of molecular alterations that provide insight into meningioma behavior and are ready for application to clinical trial investigation, and highlight the landscape of available preclinical models in meningiomas.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.004
Threshold uncertainty score0.012

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.045
GPT teacher head0.367
Teacher spread0.323 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations140
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicMeningioma and schwannoma managementFrench-language works237,207